Viewing Study NCT00161993


Ignite Creation Date: 2025-12-25 @ 1:22 AM
Ignite Modification Date: 2025-12-26 @ 12:34 AM
Study NCT ID: NCT00161993
Status: COMPLETED
Last Update Posted: 2021-08-24
First Post: 2005-09-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
Sponsor: Baxalta now part of Shire
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module